Nobivac Feline 1-HCPCh+FeLV (Eclipse 4+FELV) -25x1 Doses

MFR

Merck

Skip to the end of the images gallery

Refer Friends

Skip to the beginning of the images gallery

Be the first to review this product

SKU

002846

Shipping : Perishable

$316.99

Information

Nobivac^® Feline 1-HCPCh+FeLV (Eclipse 4 + FeLV) is recommended for the vaccination of healthy cats against diseases caused by feline Rhinotracheitis, Calici, Panleukopenia, Chlamydia Psittaci, and feline Leukemia. This is the only feline Leukemia vaccine labeled to prevent persistent viremia for two years after vaccination. Optimal choice for outdoor cats and cats that are boarded frequently. Rhinotracheitis, Calici, and Panleukopenia are modified live versions of the virus, and feline Leukemia is a killed version of the virus. Chlamydia Psittaci is killed bacteria. Recommended for use in healthy cats nine weeks of age or older.

Directions

More Information
Directions	Prior to use, warm the Nobivac® FeLV to room temperature and shake well. Transfer contents of the Nobivac^® FeLV vial to the Nobivac^® Feline 1-HCPCh vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration. Two doses are required for primary immunization. Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older. Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination. Revaccinate every two years with a single dose of Nobivac^® Feline 1-HCPCh+FeLV. Revaccination in the intervening years with Nobivac^® Feline 1-HCPCh is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.